International Network of VENous Thromboembolism Clinical Research Networks

Flag of Canada

The Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network is a pan-Canadian, patient-oriented, Community Development Program centred on venous thromboembolism (VTE) related research, training, and knowledge translation.

The purpose of CanVECTOR is to create an enduring, pan-Canadian network of stakeholders, researchers, methodology experts, knowledge transfer experts, research trainees, clinical research professionals, industry partners, public agency partners, healthcare providers, and patient groups whose combined efforts to reduce VTE occurrence, improve VTE diagnosis and therapeutic management, improve the safety of anticoagulant delivery and enhance the quality of life of those impacted by VTE, both in Canada and globally.

Council Members

Dr. Gregoire Le Gal

Dr. Gregoire Le Gal, MD, PhD

Dr. Le Gal is a Professor in the Division of Hematology of the Department of Medicine at the University of Ottawa, a physician in the Thrombosis Program, Division of Hematology at The Ottawa Hospital, and a Senior Scientist in the Ottawa Hospital Research Institute, Clinical Epidemiology Program.

Dr. Le Gal’s primary research interest is the diagnosis and management of VTE. He has over 200 peer-reviewed publications in general internal medicine and specialized journals. He is a member of the international advisory board of the Journal of Thrombosis and Haemostasis, and a reviewer for main general internal medicine and thrombosis journals. He has been the principal investigator of several multicenter multinational projects on the diagnosis and management of VTE.

Dr. Marc Rodger, MD, MSc

Dr. Rodger holds a Faculty of Medicine Clinical Research Chair in Venous Thrombosis and Thrombophilia and a Career Scientist Award from the Heart and Stroke Foundation of Canada (HSFC). Dr. Rodger founded the Ottawa Hospital General Campus Thrombosis Program in 1998, which merged with the Civic Campus Thrombosis Program (founded by Dr. Phil Wells) in 2002. Dr. Rodger led the development of the Champlain LHIN Regional Thrombosis Program which was launched in 2010 and serves a population of over 1 million. In 2012, as Chief of Hematology he also led the development of the Ottawa Blood Disease Center: A state of the art world class facility housing the clinical, research, teaching and administrative components of the Division of Hematology.

Dr. Rodger’s research program is focused on venous thrombosis and thrombophilia with specific focus on 1) thrombosis/ thrombophilia in pregnancy and 2) venous thrombosis: optimal management. With over $20 million in principal investigator funding over his lifetime to conduct research in these areas, he has generated over 200 peer-reviewed publications.

Dr. Susan Kahn

Dr. Susan Kahn, MD, MSc

Dr. Kahn is an internist and clinical epidemiologist based at the Jewish General Hospital in Montreal, where she is the founder and director of the Jewish General Hospital’s Centre of Excellence in Thrombosis and Anticoagulation Care (CETAC). She is appointed as Professor with Tenure in the Department of Medicine, McGill University, where she is Director of the McGill Thrombosis Fellowship.

Dr. Kahn’s research interests focus primarily on clinical trials of interventions to prevent, diagnose, treat, and improve outcomes of venous thromboembolism. She holds a Tier 1 Canada Research Chair in Venous Thromboembolism, and previously held a National Clinical Research Scholar award from the Fonds de recherche du Québec-Santé (FRQ-S). She has been awarded numerous peer-reviewed research grants from national and provincial funding agencies, including a 7-year CIHR Foundation grant in 2015, and has published more than 200 papers in the field of thromboembolism.


* indicates required

Contact Permissions

Please select the ways you would like to hear from INVENT Network:

Contact Permissions

By clicking below to subscribe, you agree to the terms of our privacy policy.